The mission of LLS is to cure leukemia, lymphoma, Hodgkin's Disease and myeloma, and improve the quality of patients and their families.
LS research investment has played a critical role in advancing therapies for blood cancer patients, including targeted and immunotherapies.
As there are no means of preventing or early screening for most blood cancers, the LLS research agenda is focused on finding cures. LLS funds research grants to support every discipline in the blood cancers. They partner directly with biotechnology companies to accelerate therapies. LLS has invested over 1 billion dollars in cancer research!